01 4AstraZeneca Canada Inc.
01 22843109
02 22933403
01 4OSIMERTINIB MESYLATE
01 4TABLET
01 22032-07-25
02 22035-01-02
Patent Expiration Date : 2032-07-25
Date Granted : 2015-06-16
Brand Name : TAGRISSO
Patent Number : 2843109
Filing Date : 2012-07-25
Strength per Unit : 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-07-25
Date Granted : 2015-06-16
Patent Expiration Date : 2032-07-25
Date Granted : 2015-06-16
Brand Name : TAGRISSO
Patent Number : 2843109
Filing Date : 2012-07-25
Strength per Unit : 80mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-07-25
Date Granted : 2015-06-16
Patent Expiration Date : 2035-01-02
Date Granted : 2022-03-29
Brand Name : TAGRISSO
Patent Number : 2933403
Filing Date : 2015-01-02
Strength per Unit : 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-01-02
Date Granted : 2022-03-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-01-02
Date Granted : 2022-03-29
Brand Name : TAGRISSO
Patent Number : 2933403
Filing Date : 2015-01-02
Strength per Unit : 80mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-01-02
Date Granted : 2022-03-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
